Virtu KCG Holdings’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Virtu KCG Holdings’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$433K	Buy	25,646 +14,638	+133%	+$223K	0.01%	1285
2017 Q1	$147K	Sell	11,008 -317	-3%	-$4.96K	﹤0.01%	2559
2016 Q4	$170K	Sell	11,325 -1,703	-13%	-$22.5K	﹤0.01%	2679
2016 Q3	$152K	Sell	13,028 -3,715	-22%	-$43.7K	﹤0.01%	2497
2016 Q2	$181K	Buy	+16,743	New	+$173K	﹤0.01%	2355
2016 Q1	–	Sell	-14,880	Closed	-$221K	–	3929
2015 Q4	$221K	Buy	+14,880	New	+$249K	﹤0.01%	2576
2015 Q3	–	Sell	-19,170	Closed	-$437K	–	4000
2015 Q2	$437K	Buy	+19,170	New	+$382K	0.01%	1616
2014 Q2	–	Sell	-26,897	Closed	-$313K	–	4190
2014 Q1	$313K	Buy	26,897 +16,585	+161%	+$281K	﹤0.01%	2468
2013 Q4	$182K	Buy	+10,312	New	+$173K	﹤0.01%	3182

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Virtu KCG Holdings's MNTA Position: Q2 2017 in Review

Virtu KCG Holdings increased its Momenta Pharmaceuticals, Inc. (MNTA) stake by 133% in Q2 2017, buying an estimated $223K and bringing the position to 25,646 shares worth $433K. The position accounts for 0.01% of the portfolio, ranked #1285.

Virtu KCG Holdings first reported a position in MNTA in Q4 2013 and has held it in 9 quarters since. The position peaked at $437K in Q2 2015. 164 funds tracked by Wall St. Rank hold MNTA as of Q2 2017.

Virtu KCG Holdings held 25,646 shares of Momenta Pharmaceuticals, Inc. worth $433K as of Q2 2017.
Virtu KCG Holdings bought 14,638 Momenta Pharmaceuticals, Inc. shares in Q2 2017, an estimated $223K.
Momenta Pharmaceuticals, Inc. made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1285 holding.
Virtu KCG Holdings first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2013 and has held it in 9 quarters since.
Virtu KCG Holdings's Momenta Pharmaceuticals, Inc. position peaked at $437K in Q2 2015.
164 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.